Potentially inappropriate prescribing and falls-risk increasing drugs in people who have experienced a fall: a systematic review and meta-analysis

对曾跌倒的人群进行潜在不恰当处方和增加跌倒风险药物治疗:系统评价和荟萃分析

阅读:2

Abstract

BACKGROUND: As certain medications increase risk of falls, it is important to review and optimise prescribing in those who have fallen to reduce risk of recurrent falls. OBJECTIVES: To systematically review evidence on the prevalence and types of potentially inappropriate prescribing (PIP), including falls-risk increasing drug (FRID) use, in fallers. METHODS: A systematic search was conducted in July 2024 in MEDLINE, EMBASE, CINAHL and Google Scholar using keywords for fall events, inappropriate prescribing and FRIDs. Observational studies (cohort, case-control, cross-sectional, before-after) and randomised trials were included. Studies were eligible where participants had experienced a fall and PIP (including FRID use) was reported. Random-effects meta-analyses were conducted to pool prevalence of inappropriate prescribing and mean number of inappropriate prescriptions across studies, with stratified analysis to assess heterogeneity. RESULTS: Fifty papers reporting 46 studies met the inclusion criteria. All studies assessed FRIDs, and 29 assessed other PIP. The prevalence of PIP at the time of the fall was reported in 43 studies, and the pooled estimate was 68.6% (95% CI 66.1%-71.2%). Amongst 23 studies reporting it, the mean number of inappropriate prescriptions per participant was 2.21 (95%CI 1.98-2.45). The most common FRIDs prescribed were sedatives/hypnotics, opioids, diuretics and antidepressants. Twenty-one studies assessed changes in PIP prevalence post-fall; nine reported decreasing prevalence, with others noting increases/no change/mixed results. CONCLUSION: Inappropriate prescribing is highly prevalent amongst fallers, with cardiovascular and psychotropic drugs being the most common. This suggests significant scope to optimise medicines use in these patients to potentially reduce falls risk and improve outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。